AVTX vs DAL · P/E 0.0, rev $441.0K vs P/E 12, rev $61.64B
Avalo Therapeutics Inc (AVTX) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the AVTX and DAL stock pages for the full models.
Not investment advice.